Full Text
Budget Impact Analysis of Biosimilar Infliximab Treatment for Rheumatoid Arthritis in Six Central European Countries

Abstract

Authors

V. Brodszky M. Péntek P. Baji O. Balogh N. V. Hevér L. Gulacsi

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×